Expert: Milan VaishnavThe Indian equities were gripped by selling pressure on Friday but what was noteworthy was an evident defensive approach that was at play throughout the session. Three of the top five Nifty gainers were from the pharma group. Although the Nifty Pharma index has relatively underperformed the broader markets, a few of the stocks from this pack have shown resilient performance and are set for some more upward revision of price
.png?rect=23%2C0%2C676%2C355&w=1200&auto=format%2Ccompress&ogImage=true "Biocon Closes Rs 4,500-Crore QIP At 6% Discount To Last Closing")
Pharmaceutical main Biocon Ltd. accomplished elevating of Rs 4,500 crore by means of certified institutional placement, reported the corporate on...
Ashish Kacholia Portfolio: Prime investor Ashish Kacholia, additionally recognized because the "Massive Whale" of Indian equities, has constructed his popularity by...
Nippon India Mutual Fund, BlackRock, Societe Generale, Morgan Stanley and others on Friday collectively purchased a ten per cent stake...
Because the battle between Israel and Iran hits the one-week mark, Iranians have spent almost half of the battle in...
Meta has launched passkey on Fb for cell gadgets, offering one other instrument to guard customers' privateness and safety. It...
United Spirits Ltd. might be absolutely buying Nao Spirits & Drinks Pvt. at an enterprise worth of Rs 130 crore,...
Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.
